Abstract
Full text available
Current Bioactive Compounds
Title: Anti-Microbial
Volume: 1 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Anti-Microbial, Current Bioactive Compounds 2005; 1 (3) . https://dx.doi.org/10.2174/157340705774932916
DOI https://dx.doi.org/10.2174/157340705774932916 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunity to Bacterial Infections
Current Immunology Reviews (Discontinued) Current Pharmaceutical Design of Antituberculosis Drugs: Future Perspectives
Current Pharmaceutical Design Mycobacterial tuberculosis Enzyme Targets and their Inhibitors
Current Topics in Medicinal Chemistry Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Microbial Biotransformation: Recent Developments on Steroid Drugs
Recent Patents on Biotechnology Formulation and Evaluation of Isoniazid Loaded Nanosponges for Topical Delivery
Pharmaceutical Nanotechnology 1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities
Current Computer-Aided Drug Design Current Strategies in TB Immunotherapy
Current Molecular Medicine Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients
Recent Patents on Anti-Infective Drug Discovery Potential of Natural Products of Herbal Origin as Monoamine Oxidase Inhibitors
Current Pharmaceutical Design Editorial (Thematic Issue: From Nuisance to State-of-the-Art: FDG-PET/CT Imaging of Infection and Inflammation)
Current Molecular Imaging (Discontinued) Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
Current Medicinal Chemistry Recent Advances in QSAR-based Identification and Design of Anti-Tubercular Agents
Current Pharmaceutical Design Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods
Combinatorial Chemistry & High Throughput Screening Synthesis and Biological Activity of Fused Heteropolycyclic Systems Containing an Indole Moiety
Current Organic Synthesis Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Current HIV Research Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery
Current Medicinal Chemistry S-Nitrosylation: Targets, Controls and Outcomes
Current Genomics Immune Therapy of Multiple Sclerosis - Future Strategies
Current Pharmaceutical Design Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy